CClinicalTrials.gg
Sign In
CompletedNCT01997242SAS registryUpdated Jun 26, 2025

The Surgery After Stenting (SAS) Registry

An observational study in PERCUTANEOUS CORONARY INTERVENTION, STENTS and SURGERY, sponsored by Azienda USL Reggio Emilia - IRCCS. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-26.

Sponsored by Azienda USL Reggio Emilia - IRCCS · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

The SAS registry will include any patient with previous coronary stenting undergoing any type of surgery or operative endoscopic/endovascular procedure at the participating Centers. The relevant clinical, procedural and outcome data (within index surgical admission and at 30 days) will be entered in a specifically designed electronic case record form (eCRF).

02

Conditions studied

  • PERCUTANEOUS CORONARY INTERVENTION
  • STENTS
  • SURGERY

Keywords

  • CORONARY STENT
  • CARDIAC SURGERY
  • NON CARDIAC SURGEY
03

In context

Lead sponsor

Azienda USL Reggio Emilia - IRCCS is the lead sponsor of 92 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with prior coronary stenting undergoing urgent or elective surgical/endoscopic procedures

Inclusion criteria

  • Eligible will be male and female patients > 18 years of age.
  • Eligible will be patients with previous coronary stenting undergoing any kind of surgical or operative endoscopic procedure at the participating Centers, irrespective of the distance in time between stenting and surgery.
  • Both candidates to elective/urgent operations and those undergoing emergency operations will be included in the SAS registry, and will be considered as two separate cohorts.

Exclusion criteria

Exclusion Criteria:

- Unwillingess/inability to sign the Informed Consent Form (ICF). There are no other selection criteria.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • stenting undergoing surgery

    Patients with prior coronary stenting undergoing urgent or elective surgical/endoscopic procedures

06

What researchers measure

Primary outcomes

  1. The composite of death, myocardial infarction, probable/definite stent thrombosis according the Academic Research Consortium definition and bleeding events of Bleeding Academic Research Consortium (BARC)grade >3 during index surgical admission.

    Time frame: within the first 30 days after surgery

Secondary outcomes

  1. The incidence of bleeding events of Bleeding Academic Research Consortium (BARC) grade >3 within 30 days of index admission/procedure

    Time frame: within the first 30 days after surgery

07

Study locations

1 site
  • Arcispedale Santa Maria Nuova- IRCCS
    Reggio Emilia, Italy 42123, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01997242
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Collaborators
Italian Society of Invasive Cardiology, Associazione Nazionale Medici Cardiologi Ospedalieri
Responsible party
Sponsor
First posted
Nov 28, 2013
Start date
Jun 10, 2013
Primary completion
Dec 31, 2014
Completion
Dec 31, 2014
Last update
Jun 26, 2025

Study contacts

Stefano Savonitto, MD
study chair · Division of Cardiology, Manzoni Hospital, Lecco
Roberta Rossini, MD
study chair · Cardiovascular Dpt, Ospedali Riuniti di Bergamo
Giovanni Tortorella, MD
study chair · Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia
Marco Ferri, MD
principal investigator · Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Azienda USL Reggio Emilia - IRCCS

Start the discussion